Contact: Vicki Cohn, (914) 740-2156, firstname.lastname@example.org
Festschrift Issue for Hilary Koprowski, MD published in Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
New Rochelle, NY, June 20, 2014—The June issue of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a special tribute issue for Hilary Koprowski, MD (1916-2013). The Festschrift papers are available online on the Monoclonal Antibodies in Immunodiagnosis and Immunotherapy website.
An exclusive print copy of the Festschrift will be presented to all speakers at The Wistar Institute Symposium to honor Dr. Koprowski in Philadelphia on June 27, 2014, with support from CASIS™.
“The contributors to this issue are internationally known scientists who were personally involved in Hilary Koprowski’s scientific research, including Margo Brinton, Thomas Kieber-Emmons, Barbara Knowles, Michael Oldstone, and Stanley Plotkin,” says journal Editor-in-Chief Zenon Steplewski, MD, PhD, Biotechnology Foundation Inc., Philadelphia, PA. “His lifelong achievements in biomedical research include the advancement of vaccines (he was the first to develop the basis for an oral polio vaccine) and new approaches to cancer biology studies and modern virology (development of the modern tissue cultured-based rabies vaccine). Although it was not possible to cover all areas of his work, this Festschrift gives readers an idea of the many and varied influences that Dr. Koprowski shared in the fields of bioscience.”
“CASIS is extremely proud to be a sponsor of the Festschrift issue in honor of Dr. Koprowski,” says CASIS Chief Operating Officer Duane Ratliff. “Onboard the International Space Station U.S. National Laboratory, CASIS is enabling visionary researchers to explore the advantages of a microgravity environment to enhance life science research not otherwise possible on Earth.”
About the Journal
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, published bimonthly online presents the latest developments in characterization and application of mAbs and publishes descriptions and resources of novel mAbs. The Journal’s targeted coverage advances our understanding of immune responses and is an essential resource on the use of immunological methods for experimental and therapeutic purposes for researchers and clinicians in immunology and cancer biology. Complete tables of content and a sample issue may be viewed on the Monoclonal Antibodies in Immunodiagnosis and Immunotherapy website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cancer Biotherapy and Radiopharmaceuticals, DNA and Cell Biology, AIDS Research and Human Retroviruses, ASSAY and Drug Development Technology, Human Gene Therapy, and Viral Immunology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.